{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:39:21Z","timestamp":1793691561706,"version":"4.5.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019092","name":"Science Fund for Distinguished Young Scholars of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ70014"],"award-info":[{"award-number":["2026JJ70014"]}],"id":[{"id":"10.13039\/501100019092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08565-5","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:25:38Z","timestamp":1784204738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The NLRP3 inflammasome in gastrointestinal malignancies: molecular mechanisms, regulatory networks, and therapeutic opportunities"],"prefix":"10.1186","volume":"24","author":[{"given":"Lei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-8807","authenticated-orcid":false,"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"8565_CR1","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00261-022-03788-8","volume":"48","author":"M Pectasides","year":"2023","unstructured":"Pectasides M, Sekhar A, Dighe MK, Schwartz G, Shah SN, Mulcahy MF, Horowitz JM. Gastrointestinal malignancies in pregnancy. Abdom Radiol (NY). 2023;48:1709\u201323.","journal-title":"Abdom Radiol (NY)"},{"key":"8565_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.pop.2017.07.013","volume":"44","author":"WR Sonnenberg","year":"2017","unstructured":"Sonnenberg WR. Gastrointestinal Malignancies. Prim Care. 2017;44:721\u201332.","journal-title":"Prim Care"},{"key":"8565_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2020.01.179","volume":"151","author":"DA Glencross","year":"2020","unstructured":"Glencross DA, Ho TR, Cami\u00f1a N, Hawrylowicz CM, Pfeffer PE. Air pollution and its effects on the immune system. Free Radic Biol Med. 2020;151:56\u201368.","journal-title":"Free Radic Biol Med"},{"key":"8565_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, Jing T, Yao Y, Qiu Z, Wang Z, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28:51.","journal-title":"Cell Mol Biol Lett"},{"key":"8565_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148\u201359.","journal-title":"Cell Mol Immunol"},{"key":"8565_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, Chen Y, Tan Y, Hu R. Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation. Cancer Immunol Res. 2021;9:1008\u201323.","journal-title":"Cancer Immunol Res"},{"key":"8565_CR7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-023-01148-7","volume":"30","author":"X Liu","year":"2023","unstructured":"Liu X, Fang Y, Lv X, Hu C, Chen G, Zhang L, Jin B, Huang L, Luo W, Liang G, Wang Y. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death Differ. 2023;30:1457\u201371.","journal-title":"Cell Death Differ"},{"key":"8565_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00335-018-9783-2","volume":"29","author":"AP Perera","year":"2018","unstructured":"Perera AP, Sajnani K, Dickinson J, Eri R, K\u00f6rner H. NLRP3 inflammasome in colitis and colitis-associated colorectal cancer. Mamm Genome. 2018;29:817\u201330.","journal-title":"Mamm Genome"},{"key":"8565_CR9","doi-asserted-by":"publisher","first-page":"110875","DOI":"10.1016\/j.cbi.2024.110875","volume":"390","author":"Y Cui","year":"2024","unstructured":"Cui Y, Chen XB, Liu Y, Wang Q, Tang J, Chen MJ. Piperlongumine inhibits esophageal squamous cell carcinoma in vitro and in vivo by triggering NRF2\/ROS\/TXNIP\/NLRP3-dependent pyroptosis. Chem Biol Interact. 2024;390:110875.","journal-title":"Chem Biol Interact"},{"key":"8565_CR10","doi-asserted-by":"publisher","first-page":"1326137","DOI":"10.3389\/fimmu.2024.1326137","volume":"15","author":"C Zhao","year":"2024","unstructured":"Zhao C, Mu M, Li X, Dong Z, Wang J, Yao C, Zheng J, Sun X, Yu J. USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis. Front Immunol. 2024;15:1326137.","journal-title":"Front Immunol"},{"key":"8565_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221\u20135.","journal-title":"Nature"},{"key":"8565_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"8565_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh S, Zeiser R. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword. Front Immunol. 2020;11:1444.","journal-title":"Front Immunol"},{"key":"8565_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22:550\u20139.","journal-title":"Nat Immunol"},{"key":"8565_CR15","doi-asserted-by":"publisher","first-page":"114070","DOI":"10.1016\/j.celrep.2024.114070","volume":"43","author":"T Yu","year":"2024","unstructured":"Yu T, Hou D, Zhao J, Lu X, Greentree WK, Zhao Q, Yang M, Conde DG, Linder ME, Lin H. NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. Cell Rep. 2024;43:114070.","journal-title":"Cell Rep"},{"key":"8565_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","volume":"46","author":"JE Cabral","year":"2025","unstructured":"Cabral JE, Wu A, Zhou H, Pham MA, Lin S, McNulty R. Targeting the NLRP3 inflammasome for inflammatory disease therapy. Trends Pharmacol Sci. 2025;46:503\u201319.","journal-title":"Trends Pharmacol Sci"},{"key":"8565_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2023.03.003","volume":"56","author":"F Zhu","year":"2023","unstructured":"Zhu F, Ma J, Li W, Liu Q, Qin X, Qian Y, Wang C, Zhang Y, Li Y, Jiang D, et al. The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity. 2023;56:753\u2013e767758.","journal-title":"Immunity"},{"key":"8565_CR18","doi-asserted-by":"publisher","first-page":"eabj3859","DOI":"10.1126\/sciimmunol.abj3859","volume":"6","author":"C Wang","year":"2021","unstructured":"Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, Kanneganti TD, Monahan JB, Abu-Amer Y, Lieberman J, Mbalaviele G. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 2021;6:eabj3859.","journal-title":"Sci Immunol"},{"key":"8565_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666\u201371.","journal-title":"Nature"},{"key":"8565_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D\u2019Agostino D, Planavsky N, Lupfer C, Kanneganti TD, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263\u20139.","journal-title":"Nat Med"},{"key":"8565_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","volume":"570","author":"H Sharif","year":"2019","unstructured":"Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, Hauenstein AV, Wu Z, N\u00fa\u00f1ez G, Mao Y, Wu H. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570:338\u201343.","journal-title":"Nature"},{"key":"8565_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00415-022-11491-3","volume":"270","author":"L Soraci","year":"2023","unstructured":"Soraci L, Gambuzza ME, Biscetti L, Lagan\u00e0 P, Lo Russo C, Buda A, Barresi G, Corsonello A, Lattanzio F, Lorello G, et al. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson\u2019s disease: mechanisms and therapeutic implications. J Neurol. 2023;270:1346\u201360.","journal-title":"J Neurol"},{"key":"8565_CR23","doi-asserted-by":"publisher","first-page":"108756","DOI":"10.1016\/j.celrep.2021.108756","volume":"34","author":"M Bambouskova","year":"2021","unstructured":"Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K, Swain A, Hayes S, Sheldon RD, Kim H, et al. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021;34:108756.","journal-title":"Cell Rep"},{"key":"8565_CR24","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41401-018-0160-1","volume":"39","author":"JR Zhu","year":"2018","unstructured":"Zhu JR, Lu HD, Guo C, Fang WR, Zhao HD, Zhou JS, Wang F, Zhao YL, Li YM, Zhang YD, et al. Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-\u03baB nuclear translocation. Acta Pharmacol Sin. 2018;39:1706\u201315.","journal-title":"Acta Pharmacol Sin"},{"key":"8565_CR25","doi-asserted-by":"publisher","first-page":"115233","DOI":"10.1016\/j.celrep.2025.115233","volume":"44","author":"J Schachter","year":"2025","unstructured":"Schachter J, Guijarro A, Angosto-Bazarra D, Pinilla M, Hurtado-Navarro L, Meunier E, P\u00e9rez-Oliva AB, Schwarzbaum PJ, Pelegrin P. Gasdermin D mediates a fast transient release of ATP after NLRP3 inflammasome activation before ninjurin 1-induced lytic cell death. Cell Rep. 2025;44:115233.","journal-title":"Cell Rep"},{"key":"8565_CR26","doi-asserted-by":"publisher","first-page":"167309","DOI":"10.1016\/j.jmb.2021.167309","volume":"433","author":"C Dekker","year":"2021","unstructured":"Dekker C, Mattes H, Wright M, Boettcher A, Hinniger A, Hughes N, Kapps-Fouthier S, Eder J, Erbel P, Stiefl N, et al. Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition. J Mol Biol. 2021;433:167309.","journal-title":"J Mol Biol"},{"key":"8565_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","volume":"66","author":"X Yu","year":"2017","unstructured":"Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C, Tian Z. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1\u03b2 production via suppressing the NF-\u03baB pathway and ROS production. J Hepatol. 2017;66:693\u2013702.","journal-title":"J Hepatol"},{"key":"8565_CR28","doi-asserted-by":"publisher","first-page":"1339304","DOI":"10.3389\/fimmu.2024.1339304","volume":"15","author":"TT Joseph","year":"2024","unstructured":"Joseph TT, Schuch V, Hossack DJ, Chakraborty R, Johnson EL. Melatonin: the placental antioxidant and anti-inflammatory. Front Immunol. 2024;15:1339304.","journal-title":"Front Immunol"},{"key":"8565_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-019-1761-4","volume":"10","author":"L Sun","year":"2019","unstructured":"Sun L, Ma W, Gao W, Xing Y, Chen L, Xia Z, Zhang Z, Dai Z. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell Death Dis. 2019;10:542.","journal-title":"Cell Death Dis"},{"key":"8565_CR30","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, He W, Zhang SS, Fu X, Liu J, et al. IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024;187:7248\u2013e72667234.","journal-title":"Cell"},{"key":"8565_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","volume":"18","author":"T Speer","year":"2022","unstructured":"Speer T, Dimmeler S, Schunk SJ, Fliser D, Ridker PM. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat Rev Nephrol. 2022;18:762\u201378.","journal-title":"Nat Rev Nephrol"},{"key":"8565_CR32","doi-asserted-by":"publisher","first-page":"e2309579121","DOI":"10.1073\/pnas.2309579121","volume":"121","author":"P Rozario","year":"2024","unstructured":"Rozario P, Pinilla M, Gorse L, Vind AC, Robinson KS, Toh GA, Firdaus MJ, Mart\u00ednez JF, Kerk SK, Lin Z, et al. Mechanistic basis for potassium efflux-driven activation of the human NLRP1 inflammasome. Proc Natl Acad Sci U S A. 2024;121:e2309579121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8565_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","volume":"560","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, Wong J, Ding S, Seki E, Schnabl B, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560:198\u2013203.","journal-title":"Nature"},{"key":"8565_CR34","doi-asserted-by":"crossref","unstructured":"Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, Bitto A, Crea G, Pisani A, Squadrito F, et al. ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury. Oxid Med Cell Longev. 2016;2016:2183026.","DOI":"10.1155\/2016\/2183026"},{"key":"8565_CR35","doi-asserted-by":"crossref","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sc. 2019;20.","DOI":"10.3390\/ijms20133328"},{"key":"8565_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.65.14.34","volume":"65","author":"Z Zha","year":"2024","unstructured":"Zha Z, Xiao D, Liu Z, Peng F, Shang X, Sun Z, Liu Y, Chen W. Endoplasmic Reticulum Stress Induces ROS Production and Activates NLRP3 Inflammasome Via the PERK-CHOP Signaling Pathway in Dry Eye Disease. Invest Ophthalmol Vis Sci. 2024;65:34.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8565_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","volume":"564","author":"J Chen","year":"2018","unstructured":"Chen J, Chen ZJ. PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 2018;564:71\u20136.","journal-title":"Nature"},{"key":"8565_CR38","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1016\/j.molcel.2023.11.015","volume":"83","author":"S Zheng","year":"2023","unstructured":"Zheng S, Que X, Wang S, Zhou Q, Xing X, Chen L, Hou C, Ma J, An P, Peng Y, et al. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Mol Cell. 2023;83:4570\u2013e45854577.","journal-title":"Mol Cell"},{"key":"8565_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2025.10.008","volume":"47","author":"O Dufies","year":"2026","unstructured":"Dufies O, Zanoni I. Post-translational modifications of NLRP3: to prime or not to prime? Trends Immunol. 2026;47:119\u201329.","journal-title":"Trends Immunol"},{"key":"8565_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12964-025-02426-2","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Usman M, Wu Q, Gao Y, Fu L, Chu M, Jia C. The impact of post-translational modifications and subcellular localization on NLRP3 inflammasome activation: A systematic review. Cell Commun Signal. 2025;23:426.","journal-title":"Cell Commun Signal"},{"key":"8565_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356:513\u20139.","journal-title":"Science"},{"key":"8565_CR42","doi-asserted-by":"publisher","first-page":"19609","DOI":"10.1038\/s41598-025-04823-6","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang Y, Xing H, Bai Y, Li M, Zhao H, Ding L, Wang W, Bao T. Association between endogenous lactate accumulation and dysregulated activation of the NLRP3 inflammasome pathway in schizophrenia. Sci Rep. 2025;15:19609.","journal-title":"Sci Rep"},{"key":"8565_CR43","doi-asserted-by":"publisher","first-page":"e032904","DOI":"10.1161\/JAHA.123.032904","volume":"13","author":"WB Liu","year":"2024","unstructured":"Liu WB, Wang SS, Zhang X, Ke ZZ, Wen XY, Zhao J, Zhuang XD, Liao LZ. Enhanced Cardiomyocyte NLRP3 Inflammasome-Mediated Pyroptosis Promotes d-Galactose-Induced Cardiac Aging. J Am Heart Assoc. 2024;13:e032904.","journal-title":"J Am Heart Assoc"},{"key":"8565_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40168-024-01826-9","volume":"12","author":"X Zhou","year":"2024","unstructured":"Zhou X, Ji S, Chen L, Liu X, Deng Y, You Y, Wang M, He Q, Peng B, Yang Y, et al. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome. Microbiome. 2024;12:109.","journal-title":"Microbiome"},{"key":"8565_CR45","doi-asserted-by":"publisher","first-page":"103746","DOI":"10.1016\/j.redox.2025.103746","volume":"85","author":"H Wu","year":"2025","unstructured":"Wu H, Li YL, Wang Y, Wang YG, Hong JH, Pang MM, Liu PM, Yang JJ. Anemoside B4 alleviates ulcerative colitis by attenuating intestinal oxidative stress and NLRP3 inflammasome via activating aryl hydrocarbon receptor through remodeling the gut microbiome and metabolites. Redox Biol. 2025;85:103746.","journal-title":"Redox Biol"},{"key":"8565_CR46","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1002\/ctm2.1692","volume":"14","author":"X Guan","year":"2024","unstructured":"Guan X, Liu R, Wang B, Xiong R, Cui L, Liao Y, Ruan Y, Fang L, Lu X, Yu X, et al. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3\/GSDMD-mediated pyroptosis in colorectal cancer. Clin Transl Med. 2024;14:e1692.","journal-title":"Clin Transl Med"},{"key":"8565_CR47","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1038\/s41467-024-49549-7","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, Mao R, Yuan S, Xie Q, Meng J, Gu Y, Tan S, Xu X, Gao C, Liu H, et al. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nat Commun. 2024;15:5170.","journal-title":"Nat Commun"},{"key":"8565_CR48","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan H, Wang Z, Teng D, Chen X, Zhu Z, Chen H, Wang W, Wei Z, Wu Z, Chai Q, et al. Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metab. 2024;36:2449\u2013e24672446.","journal-title":"Cell Metab"},{"key":"8565_CR49","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/2159-8290.CD-23-1300","volume":"14","author":"M Matusiak","year":"2024","unstructured":"Matusiak M, Hickey JW, van Lu IDGP, Kidzi\u0144ski G, Zhu L, Colburg S, Luca DRC, Phillips B, Brubaker DJ. Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer. Cancer Discov. 2024;14:1418\u201339.","journal-title":"Cancer Discov"},{"key":"8565_CR50","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/17520363.2024.2416886","volume":"18","author":"A Mo","year":"2024","unstructured":"Mo A, Wang H. WTAP-mediated m6A modification regulates NLRP3\/Caspase-1\/GSDMD to inhibit pyroptosis and exacerbate colorectal cancer. Biomark Med. 2024;18:945\u201355.","journal-title":"Biomark Med"},{"key":"8565_CR51","doi-asserted-by":"publisher","first-page":"156194","DOI":"10.1016\/j.phymed.2024.156194","volume":"135","author":"G Zhang","year":"2024","unstructured":"Zhang G, Yao Y, Zhang Z, Xiao J, Yu H, Zhao J, Yao C, Wang Y, Luo H. Regulation of NLRP3 inflammasome and Caspase-3\/4\/11 by 2\u2019,4\u2019-dihydroxychalcone contributes to anti-colorectal cancer. Phytomedicine. 2024;135:156194.","journal-title":"Phytomedicine"},{"key":"8565_CR52","doi-asserted-by":"publisher","first-page":"674340","DOI":"10.3389\/fphar.2021.674340","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Yu Y, Yang C, Wang Z, Yang Y, Wang C, Zheng Q, Li D, Xu W. Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission. Front Pharmacol. 2021;12:674340.","journal-title":"Front Pharmacol"},{"key":"8565_CR53","doi-asserted-by":"crossref","unstructured":"Arr\u00e8 V, Scavo MP, Donghia R, Dituri F, Mandorino C, Cassotta M, Ancona A, Balestra F, Vincenti L, Aquilino F, et al. Inorganic polyphosphate triggers nlrp3 inflammasome and promotes the epithelial-to-mesenchymal transition and migration of colorectal cancer cells through TRPM8 receptor. Int J Mol Sci. 2025;26.","DOI":"10.3390\/ijms26167743"},{"key":"8565_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00262-025-04088-y","volume":"74","author":"C Mowat","year":"2025","unstructured":"Mowat C, Schiller D, Baker K. NLRP3 activation promotes cGAS\/STING signaling and antitumor immunity by colorectal cancer cells. Cancer Immunol Immunother. 2025;74:238.","journal-title":"Cancer Immunol Immunother"},{"key":"8565_CR55","doi-asserted-by":"publisher","first-page":"e931630","DOI":"10.12659\/MSM.931630","volume":"27","author":"C Zhang","year":"2021","unstructured":"Zhang C, Luo CL, Shang GS, Jiang DX, Song Q. Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation. Med Sci Monit. 2021;27:e931630.","journal-title":"Med Sci Monit"},{"key":"8565_CR56","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/07853890.2022.2061045","volume":"54","author":"M Liang","year":"2022","unstructured":"Liang M, Liu Y, Zhang Z, Yang H, Dai N, Zhang N, Sun W, Guo Y, Kong J, Wang X, et al. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance. Ann Med. 2022;54:989\u20131003.","journal-title":"Ann Med"},{"key":"8565_CR57","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jat.4332","volume":"42","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhao C, Zhou J, Zhang H, Zhang Y, Wang S, Pu Y, Yin L. Reactive oxygen species-mediated activation of NLRP3 inflammasome associated with pyroptosis in Het-1A cells induced by the co-exposure of nitrosamines. J Appl Toxicol. 2022;42:1651\u201361.","journal-title":"J Appl Toxicol"},{"key":"8565_CR58","doi-asserted-by":"crossref","unstructured":"Luo T, Zhou X, Qin M, Lin Y, Lin J, Chen G, Liu A, Ouyang D, Chen D, Pan H. corilagin restrains NLRP3 inflammasome activation and pyroptosis through the ROS\/TXNIP\/NLRP3 pathway to prevent inflammation. Oxid Med Cell Longe. 2022;2022:1652244.","DOI":"10.1155\/2022\/1652244"},{"key":"8565_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/15384101.2025.2539656","volume":"24","author":"F Li","year":"2025","unstructured":"Li F, Qian Y, Mo Y, Feng L. THBS1 knockdown and baicalin induce pyroptosis via the NF-\u03baB-NLRP3-Caspase-1 axis in gastric cancer cells. Cell Cycle. 2025;24:183\u2013203.","journal-title":"Cell Cycle"},{"key":"8565_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00011-021-01522-6","volume":"71","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li C, Chen D, He X, Zhao Y, Bao L, Wang Q, Zhou J, Xie Y. H. pylori CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion. Inflamm Res. 2022;71:141\u201355.","journal-title":"Inflamm Res"},{"key":"8565_CR61","doi-asserted-by":"publisher","first-page":"14335","DOI":"10.1038\/s41598-025-98301-8","volume":"15","author":"C Wan","year":"2025","unstructured":"Wan C, Wang P, Xu Y, Zhu Y, Chen H, Cao X, Gu Y. Mechanism and role of H. pylori CagA-induced NLRP3 inflammasome in gastric cancer immune cell infiltration. Sci Rep. 2025;15:14335.","journal-title":"Sci Rep"},{"key":"8565_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2023.03.024","volume":"202","author":"X Zeng","year":"2023","unstructured":"Zeng X, Yang M, Ye T, Feng J, Xu X, Yang H, Wang X, Bao L, Li R, Xue B, et al. Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-\u043aB axis. Free Radic Biol Med. 2023;202:46\u201361.","journal-title":"Free Radic Biol Med"},{"key":"8565_CR63","doi-asserted-by":"publisher","first-page":"e28672","DOI":"10.1016\/j.heliyon.2024.e28672","volume":"10","author":"X Qi","year":"2024","unstructured":"Qi X, Liu J, Wang L, Gu P, Song S, Shu P. Kaempferol-induced mitochondrial damage promotes NF-\u03baB-NLRP3-caspase-1 signaling axis-mediated pyroptosis in gastric cancer cells. Heliyon. 2024;10:e28672.","journal-title":"Heliyon"},{"key":"8565_CR64","doi-asserted-by":"crossref","unstructured":"Sohrab SS, Raj R, Nagar A, Hawthorne S, Paiva-Santos AC, Kamal MA, El-Daly MM, Azhar EI, Sharma A. Chronic Inflammation\u2019s transformation to cancer: a nanotherapeutic paradigm. Molecule. 2023;28.","DOI":"10.3390\/molecules28114413"},{"key":"8565_CR65","doi-asserted-by":"crossref","unstructured":"Li W, Zhang L, Xu Q, Yang W, Zhao J, Ren Y, Yu Z, Ma L. Taxifolin alleviates DSS-induced ulcerative colitis by acting on gut microbiome to produce butyric acid. Nutrient. 2022;14.","DOI":"10.3390\/nu14051069"},{"key":"8565_CR66","doi-asserted-by":"publisher","first-page":"115209","DOI":"10.1016\/j.intimp.2025.115209","volume":"163","author":"S Chen","year":"2025","unstructured":"Chen S, Yan L, Zeng J, Meng W, Zhuang J, Chen F, Guo Y, Abd El-Aty AM, Ju X, Yang S. Therapeutic effects of D-cycloserine in mouse models of IBD and CAC: Targeting NLRP3 inflammasome and intestinal barrier integrity. Int Immunopharmacol. 2025;163:115209.","journal-title":"Int Immunopharmacol"},{"key":"8565_CR67","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41419-025-07898-1","volume":"16","author":"S Li","year":"2025","unstructured":"Li S, Xia Q, He Y, Wu W, Tang D, Deng Z, Zeng Z, Tu S, Chen B, Gu L, et al. Peroxiredoxin 1 promotes intestinal inflammation by activating the NLRP3 inflammasome in macrophages through lysosomal disruption in Crohn\u2019s disease. Cell Death Dis. 2025;16:565.","journal-title":"Cell Death Dis"},{"key":"8565_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/ijp.ijp_678_24","volume":"58","author":"L Han","year":"2026","unstructured":"Han L, Deng XZ, Li Y, Hui J. Astilbin ameliorates intestinal inflammation and suppresses colorectal cancer cell proliferation by regulating NLRP3 inflammasome and nuclear factor-kappa B signaling pathway. Indian J Pharmacol. 2026;58:46\u201367.","journal-title":"Indian J Pharmacol"},{"key":"8565_CR69","doi-asserted-by":"publisher","first-page":"1791509","DOI":"10.3389\/fphar.2026.1791509","volume":"17","author":"Z Li","year":"2026","unstructured":"Li Z, Dawson ZD, Li X, Zhao S, Bu M, Jiang F, Chen Y, Zhang M, Zeng X, Park KH, et al. MG53 protects against intestinal inflammation by inhibiting NLRP3 inflammasome activation. Front Pharmacol. 2026;17:1791509.","journal-title":"Front Pharmacol"},{"key":"8565_CR70","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2147\/ITT.S495564","volume":"13","author":"W Pan","year":"2024","unstructured":"Pan W, Jia Z, Du J, Chang K, Liu Y, Liu W, Zhao X, Tan W. NLRP3 Inflammasome Upregulates PD-L1 in Ovarian Cancer and Contributes to an Immunosuppressive Microenvironment. Immunotargets Ther. 2024;13:775\u201388.","journal-title":"Immunotargets Ther"},{"key":"8565_CR71","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s00262-023-03471-x","volume":"72","author":"HB Barsoumian","year":"2023","unstructured":"Barsoumian HB, He K, Hsu E, Bertolet G, Sezen D, Hu Y, Riad TS, Cortez MA, Welsh JW. NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model. Cancer Immunol Immunother. 2023;72:3003\u201312.","journal-title":"Cancer Immunol Immunother"},{"key":"8565_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41419-024-06535-7","volume":"15","author":"L Shojaie","year":"2024","unstructured":"Shojaie L, Bogdanov JM, Alavifard H, Mohamed MG, Baktash A, Ali M, Mahov S, Murray S, Kanel GC, Liu ZX, et al. Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death Dis. 2024;15:140.","journal-title":"Cell Death Dis"},{"key":"8565_CR73","doi-asserted-by":"publisher","first-page":"111559","DOI":"10.1016\/j.intimp.2024.111559","volume":"129","author":"KY Chen","year":"2024","unstructured":"Chen KY, Liu SY, Tang JJ, Liu MK, Chen XY, Liu ZP, Ferrandon D, Lai KF, Li Z. NLRP3 knockout in mice provided protection against Serratia marcescens-induced acute pneumonia by decreasing PD-L1 and PD-1 expression in macrophages. Int Immunopharmacol. 2024;129:111559.","journal-title":"Int Immunopharmacol"},{"key":"8565_CR74","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-24-2905","volume":"84","author":"W Zhen","year":"2024","unstructured":"Zhen W, Chen X. Inflammasome-Activating Nanovaccine for Cancer Immunotherapy. Cancer Res. 2024;84:3709\u201311.","journal-title":"Cancer Res"},{"key":"8565_CR75","doi-asserted-by":"publisher","first-page":"108545","DOI":"10.1016\/j.pharmthera.2023.108545","volume":"251","author":"IW Tengesdal","year":"2023","unstructured":"Tengesdal IW, Dinarello CA, Marchetti C. NLRP3 and cancer: Pathogenesis and therapeutic opportunities. Pharmacol Ther. 2023;251:108545.","journal-title":"Pharmacol Ther"},{"key":"8565_CR76","doi-asserted-by":"publisher","first-page":"839460","DOI":"10.3389\/fimmu.2022.839460","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, He D, Zhang S, Chen H, Zhao J, Li X, Zeng X. Homogeneous Polyporus Polysaccharide Inhibit Bladder Cancer by Resetting Tumor-Associated Macrophages Toward M1 Through NF-\u03baB\/NLRP3 Signaling. Front Immunol. 2022;13:839460.","journal-title":"Front Immunol"},{"key":"8565_CR77","doi-asserted-by":"crossref","unstructured":"Sun S, Gong D, Liu R, Wang R, Chen D, Yuan T, Wang S, Xing C, Lv Y, Du G, Fang L. Puerarin inhibits NLRP3-caspase-1-GSDMD-mediated pyroptosis via P2X7 receptor in cardiomyocytes and macrophages. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms241713169"},{"key":"8565_CR78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"8565_CR79","doi-asserted-by":"publisher","first-page":"119272","DOI":"10.1016\/j.jep.2024.119272","volume":"340","author":"J Liu","year":"2025","unstructured":"Liu J, Chen Y, Zhang J, Zheng Y, An Y, Xia C, Chen Y, Huang S, Hou S, Deng D. Vitexin alleviates MNNG-induced chronic atrophic gastritis via inhibiting NLRP3 inflammasome. J Ethnopharmacol. 2025;340:119272.","journal-title":"J Ethnopharmacol"},{"key":"8565_CR80","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1002\/mco2.447","volume":"4","author":"W Liu","year":"2023","unstructured":"Liu W, Zhang F, Quan B, Yao F, Chen R, Ren Z, Yin X. NLRP3\/IL-1\u03b2 induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma. MedComm (2020). 2023;4:e447.","journal-title":"MedComm (2020)"},{"key":"8565_CR81","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","volume":"178","author":"H Li","year":"2007","unstructured":"Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol. 2007;178:5271\u20136.","journal-title":"J Immunol"},{"key":"8565_CR82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai T, Ikegawa M, Ori D, Akira S. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity. 2024;57:649\u201373.","journal-title":"Immunity"},{"key":"8565_CR83","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"8565_CR84","doi-asserted-by":"publisher","first-page":"102282","DOI":"10.1016\/j.molmet.2025.102282","volume":"103","author":"J Bultinck","year":"2026","unstructured":"Bultinck J, Yuan S, Cantuti-Castelvetri L, Brosens L, Bracke D, Collins J, Goethals J, Christianson C, Nuss J, Ogilvie K. NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice. Mol Metab. 2026;103:102282.","journal-title":"Mol Metab"},{"key":"8565_CR85","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/jpet.123.002013","volume":"388","author":"P Thornton","year":"2024","unstructured":"Thornton P, Reader V, Digby Z, Smolak P, Lindsay N, Harrison D, Clarke N, Watt AP. Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796. J Pharmacol Exp Ther. 2024;388:813\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"8565_CR86","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","volume":"10","author":"A S\u00e1nchez-Fern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Fern\u00e1ndez A, Skouras DB, Dinarello CA, L\u00f3pez-Vales R. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis. Front Immunol. 2019;10:2578.","journal-title":"Front Immunol"},{"key":"8565_CR87","doi-asserted-by":"crossref","unstructured":"Nelson BE, O\u2019Brien S, Sheth RA, Hong DS, Naing A, Zhang X, Xu A, Hamuro L, Suryawanshi R, McKinley D, et al. Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors. J Immunother Cancer. 2025;13.","DOI":"10.1136\/jitc-2024-010013"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08565-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:04:50Z","timestamp":1791907490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08565-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8565"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08565-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This declaration is not applicable as the study does not involve human or animal subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1289"}}